← Back to headlines
Jim Cramer Reevaluates Novo Nordisk (NVO) as Wegovy Pill Adoption Accelerates
Jim Cramer is reevaluating Novo Nordisk (NVO) as the adoption of its Wegovy pill accelerates, indicating a potential shift in market dynamics.
14 Aug, 23:42 — 14 Aug, 23:42
Sources
Showing 1 of 1 sources
